Clinical Trial Update: Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing Leridistim with Filgrastim in older adults with acute myeloid leukemia to assess safety and effectiveness in treating neutropenia and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Filgrastim (filgrastim)
• Leridistim (leridistim)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Anemia, Leukemia | Phase 2 | Status: COMPLETED